Goodwin, Covington Lead Braveheart Bio's $383M IPO
Venture-backed biotechnology firm Braveheart Bio hit the public markets on Thursday after raising $383 million in its upsized initial public offering....To view the full article, register now.
Already a subscriber? Click here to view full article